Your email has been successfully added to our mailing list.

×
0 0.00174825174825171 -0.00524475524475529 -0.00174825174825187 -0.0104895104895106 -0.0262237762237763 -0.0244755244755246 -0.020979020979021
Stock impact report

Clovis Oncology up 10% as Citadel buys in [Seeking Alpha]

Clovis Oncology, Inc. (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
Company Research Source: Seeking Alpha
Beaten-down biotech Clovis Oncology ( CLVS ) is trying to reverse its lengthy down trend, albeit on average volume. Shares have lost over   of their value since late February. Today, stockholder Citadel Advisors LLC disclosed a 7.0% stake of ~3.96M common shares. See all stocks on the move » Now read: Evofem To Bring A Unique Product To Growing Market » Subscribe for full text news in your inbox Show less Read more
Impact Snapshot
Event Time:
CLVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CLVS alerts
Opt-in for
CLVS alerts

from News Quantified
Opt-in for
CLVS alerts

from News Quantified